1-3 of 3
Pari Ramzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Chaitra S. Ujjani, MD, Catherine Lai, MD MPH, Lori A. Leslie, MD, Pari Ramzi, RN, Ming Tan, Siyu Wang, Hongkun Wang, Eunice Shim, Nicole Swanson, Catherine M Broome, Ajay K. Gopal, MD, Stephen D. Smith, MD, Edus H. Warren, MD PhD, Katie Blue, Sabrina Kdiry, BSN, Brian G. Till, MD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Michael Johnson, Hilary Coye, PA-C, Megan Shelby, PA-C, Yolanda D. Tseng, MD, Andrei Shustov, MD, David G. Maloney, MD PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-136219
Published: 2020
Journal Articles

Phase 1 Study of Lenalidomide and Ibrutinib in Combination with Rituximab in Relapsed and Refractory CLL and SLL

Chaitra S. Ujjani, MD, Hongkun Wang, PhD, Alan P Skarbnik, MD, Neel Trivedi, MD, Pari Ramzi, RN, Nadia Khan, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4324.
https://doi.org/10.1182/blood.V130.Suppl_1.4324.4324
Published: 2017
Journal Articles

Ofatumumab and Bendamustine in Previously Treated CLL and SLL

Chaitra S. Ujjani, MD, Edmund A Gehan, Pari Ramzi, Catherine Broome, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2011) 118 (21): 4615.
https://doi.org/10.1182/blood.V118.21.4615.4615
Published: 2011